Search Results - Qiaoyan Zheng

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial by Maojin You, Qiaoyan Zheng, Ying He

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: